RPWB is
not taking new clients for Baycol, but don't hesitate to
contact us with any questions or if you'd like to explore your legal rights concerning another pharmaceutical drug.
Baycol was originally approved for sale in the United States in 1997 and is a member of a class of drugs commonly referred to as "statins." These drugs function to lower cholesterol by blocking a chemical in the body that is involved in making cholesterol. Numerous cases of a condition known as rhabdomylosis have been reported by people who have taken Baycol. There is also an increased incidence of rhabdomylosis injury and death from the use of Baycol in combination with another drug commonly known as Lopid (gemfibrozil). Because of these problems, Baycol was removed from the market August 8, 2001.
Baycol has been known to cause rhabdomylosis by breaking down muscle cells which are released into the bloodstream where they are eventually processed by the kidneys. When these cells released by the side effects of Baycol reach the kidneys, they can cause kidney damage, kidney failure, and death. The first symptoms of rhabdomylosis are usually severe muscle pain in the legs and back.
